ARS Pharmaceuticals, Inc. (SPRY) Stock Price, Quote, News & Analysis

SPRY ARS Pharmaceuticals, Inc.
Earnings Date & History

$8.980.18 (+2.05%)4:00 PM 05/24/24
NASDAQ | $USD | Post-Market: $9.11 +0.13 (+1.45%) 7:38 PM

SPRY Latest Quarter's Earnings

Announce Date
EPS Normalized Actual
-$0.11 (In-Line)
EPS GAAP Actual
-$0.11 (In-Line)
Revenue Actual
$0.00
Revenue Surprise
In-Line

SPRY Upcoming Qr. Earnings

Announce Date
8/8/2024 (Post-Market)
EPS Normalized Estimate
-$0.12
EPS GAAP Estimate
-$0.12
Revenue Estimate
$1.00M
EPS Revisions (Last 90 Days)*
00

Revisions Grade

SPRY Revisions Grade

Type
SPRY
Sector Median
% Diff. to Sector
SPRY 5Y Avg.
% Diff. to 5Y Avg.
FY1 Up Revisions (last 90 days)
2(100.00%)
55.28%
80.90%
49.19%
103.29%
FY1 Down Revisions (last 90 days)
0(0.00%)
44.49%
NM
50.81%
NM

*Grades are relative to the Health Care sector

**NM signifies a non meaningful value. A dash signifies the data is not available.

Annual EPS Estimate

Fiscal Period Ending
EPS Estimate
Forward PE
LowHigh
# of Analysts
Dec 2024-0.610.00-0.69-0.532
Dec 2025-0.380.00-0.650.033

Annual Revenue Estimate

Fiscal Period Ending
Revenue Estimate
Forward P/S
LowHigh
# of Analysts
Dec 20246.21M0.004.68M8.00M3
Dec 202585.45M0.0055.36M137.00M3

SPRY Earnings History

PeriodEPSBeat / MissRevenueYoYBeat / Miss

Earnings history by period FQ1 2024 (Mar 2024)

-0.11
0.00
0.00-
0.00

Earnings history by period FQ4 2023 (Dec 2023)

-0.07
0.07
0.00-
0.00

Earnings history by period FQ3 2023 (Sep 2023)

-0.16
0.02
0.00-
0.00

Earnings history by period FQ2 2023 (Jun 2023)

-0.18
-0.01
10.00K-
10.00K
* EPS estimates are GAAP unless otherwise noted.

People Also Follow